Back to All Studies

Sepsis, a severe bacterial infection, is a leading cause of death in foals in their first weeks of life and new strategies are needed to help save these young patients. Researchers will study the effects of a novel adjunct therapeutic strategy coined “metabolic resuscitation” – a combination treatment of hydrocortisone, thiamin and vitamin C – and its potential to reduce inflammation and improve outcomes for septic foals. Recent studies report nearly one-third less deaths when this treatment combination is administered to septic human patients in conjunction with standard-of-care treatment. Researchers will gather preliminary data to evaluate the metabolic resuscitation strategy and its potential to improve survival rates of septic foals. 

Study ID
Study Status
Start Date
Grant amount awarded
Grant recipient
The University of Georgia
Study country
United States
Kelsey A. Hart, DVM, DACVIM
Study category